Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Lymphoma 13Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Leukemia 7Breast Neoplasms 7Neuroblastoma 6Neoplasms, Plasma Cell 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Prostatic Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Seminoma 2Ovarian Neoplasms 2

Interventions

Dexamethasone 3isatuximab 2Lenalidomide 2Cyclophosphamide 2pomalidomide 1fludarabine phosphate 1fludarabine 1daratumumab 1Watchful Waiting 1Vorinostat 1Vincristine 1Specimen Handling 1Rituximab 1Ranitidine 1R-CHOP protocol 1Prednisone 1Interviews as Topic 1Injections 1Histone Deacetylase Inhibitors 1Filgrastim 1Exercise 1Doxorubicin 1Diphenhydramine 1Data Collection 1Bortezomib 1Acetaminophen 1AC protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hematologic Diseases × Filgrastim × Clear all
NCT02806791 2016-06-21

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Azienda Ospedaliera San Giovanni Battista

Unknown
300 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡